We are monitoring the impact of COVID-19 on Europe Regenerative Medicines Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 242
Share on
Share on

Europe Regenerative Medicines Market Research Report – Segmented By Product, By Therapy, By Application & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Size, Share, Trends, Growth, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 242
Pages: 138

The European Regenerative Medicines Market was valued at USD 5.06 billion in 2020 and is expected to reach USD 13.56 billion by 2025, growing at a CAGR of 21.80% during the forecast period.

The European nation has strong biotechnology sectors in the UK & Germany countries. Increasing support from the government & private sectors is driving the demand for the regenerative medicine market. According to the Alliance for Regenerative Medicine, there are around 400+ companies of regenerative medicines in Europe. Adoption of the computational tools in the healthcare industry will accelerate the growth rate of the market. Bioinformatics tools provide high-resolution data, algorithms & strategies for regenerative medicines. According to the World Health Organization, there are 60 million people are diagnosed with diabetes in the European region. An increasing number of patients with diabetes is surging the growth of the regenerative medicine market in Europe.

Increasing aging population, a growing number of lifestyle disorders (diabetes, obesity), rising advancements in the research & development, an increasing number of people suffering from chronic disorders (such as liver diseases, blood disorders), and growing involvement of government to help research institutes for the development of regenerative medicines are driving the growth of regenerative medicines market in Europe.

However, the presence of uncertain regulatory guidelines and stringent ethical laws to conduct research & developments in tissue-engineered products & cell-based products are restraining the growth of the regenerative medicines market in Europe.

This research report segmented and sub-segmented into the following categories:

  • By Product: Cell-Based Products, Acellular Products
  • By Therapy: Cell Therapy, Gene Therapy, Tissue Engineering, and Immunotherapy
  • By Application: Orthopedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System, Oncology, Diabetes, and Other Application
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Regional Analysis

The regenerative medicines market in the UK is ruling with dominant shares of the market. Support from the government through investments in the development of innovative products is boosting up the growth of the market. On-going research and development may also impact positively on the growth of the market. 

Germany Regenerative Medicines Market is next to the UK is leading the highest shares of the European market by owing to the increasing incidences of chronic diseases. Prevalence of quality treatment procedures is propelling the demand of the market. 

Notable companies operating in the Europe Regenerative Medicines Market Vertex Pharmaceuticals Incorporated, Acelity L.P. Inc., Celgene Corporation, StemCells, Inc., Organogenesis Inc., NuVasive, Inc., Vericel Corporation (Genzyme), Japan Tissue Engineering Co., Ltd., Cytori Therapeutics Inc., Advantagene, Inc. and Mesoblast Ltd. (Australia).

 1.Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Introduction                                                               

                5.2  Product                                                       

                                5.2.1 Introduction                                           

                                5.2.2 Cell-Based Products                                            

                                                5.2.2.1 Autologous Cell-Based Products                

                                                5.2.2.2 Allogeneic Cell-Based Products                  

                                5.2.3 Acellular Products                                

                5.3 Therapy                                                       

                                5.3.1 Introduction                                           

                                5.3.2 Cell Therapy                                           

                                5.3.3 Gene Therapy                                       

                                5.3.4 Tissue Engineering                                               

                                5.3.5 Immunotherapy                                   

                5.4 Application                                                 

                                5.4.1 Introduction                                           

                                5.4.2 Orthopedic & Musculoskeletal Spine                                           

                                5.4.3 Dermatology                                          

                                5.4.4 Cardiovascular                                       

                                5.4.5 Central Nervous System                                   

                                5.4.6 Oncology                                 

                                5.4.7 Diabetes                                  

                                5.4.8 Other Applications                                               

6. Geographical Analysis                                                                              

                                6.2.1 Introduction                                           

                                6.2.2 U.K                                             

                                6.2.3 Spain                                         

                                6.2.4 Germany                                 

                                6.2.5 Italy                                            

                                6.2.6 France                                       

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Vertex Pharmaceuticals Incorporated (U.S.)                                                

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Acelity L.P. Inc. (U.S.)                                                             

                8.3 Celgene Corporation (U.S.)                                                 

                8.4 StemCells, Inc. (U.S.)                                                              

                8.5 Organogenesis Inc.  (U.S.)                                                    

                8.6 NuVasive, Inc. (U.S.)                                                              

                8.7 Vericel Corporation (Genzyme) (U.S.)                                                            

                8.8 Cytori Therapeutics Inc. (U.S.)                                                            

                8.9 Advantagene, Inc. (U.S.)                                                      

                8.10 Mesoblast Ltd. (Australia)                                                  

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Expert Opinions                                                                         

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                               

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  2. Europe Regenerative Medicines Market, By Product, From 2020 to 2025 (USD Billion)
  3. Europe Cell-Based Products Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Acellular Products Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Regenerative Medicines Market, By Therapy, From 2020 to 2025 (USD Billion)
  6. Europe Cell Therapy Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Gene Therapy Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Tissue Engineering Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Immunotherapy Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  10. Europe Regenerative Medicines Market, By Application, From 2020 to 2025 (USD Billion)
  11. Europe Orthopedic & Musculoskeletal Spine Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Dermatology Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Cardiovascular Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Central Nervous System Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  15. Europe Oncology Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  16. Europe Diabetes Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  17. Europe Other Applications of Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  18. U.K Regenerative Medicines Market, By Product, From 2020 to 2025 (USD Billion)
  19. U.K Regenerative Medicines Market, By Therapy, From 2020 to 2025 (USD Billion)
  20. U.K Regenerative Medicines Market, By Application, From 2020 to 2025 (USD Billion)
  21. Spain Regenerative Medicines Market, By Product, From 2020 to 2025 (USD Billion)
  22. Spain Regenerative Medicines Market, By Therapy, From 2020 to 2025 (USD Billion)
  23. Spain Regenerative Medicines Market, By Application, From 2020 to 2025 (USD Billion)
  24. Germany Regenerative Medicines Market, By Product, From 2020 to 2025 (USD Billion)
  25. Germany Regenerative Medicines Market, By Therapy, From 2020 to 2025 (USD Billion)
  26. Germany Regenerative Medicines Market, By Application, From 2020 to 2025 (USD Billion)
  27. Italy Regenerative Medicines Market, By Product, From 2020 to 2025 (USD Billion)
  28. Italy Regenerative Medicines Market, By Therapy, From 2020 to 2025 (USD Billion)
  29. Italy Regenerative Medicines Market, By Application, From 2020 to 2025 (USD Billion)
  30. France Regenerative Medicines Market, By Product, From 2020 to 2025 (USD Billion)
  31. France Regenerative Medicines Market, By Therapy, From 2020 to 2025 (USD Billion)
  32. France Regenerative Medicines Market, By Application, From 2020 to 2025 (USD Billion)
  33. Europe Cell-Based Products Regenerative Medicines Market, By Type, From 2020 to 2025 (USD Billion)
  34. Europe Autologous Cell-Based Products Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  35. Europe Allogeneic Cell-Based Products Regenerative Medicines Market, By Region, From 2020 to 2025 (USD Billion)
  36. U.K Cell-Based Products Regenerative Medicines Market, By Type, From 2020 to 2025 (USD Billion)
  37. Spain Cell-Based Products Regenerative Medicines Market, By Type, From 2020 to 2025 (USD Billion)
  38. Germany Cell-Based Products Regenerative Medicines Market, By Type, From 2020 to 2025 (USD Billion)
  39. Italy Cell-Based Products Regenerative Medicines Market, By Type, From 2020 to 2025 (USD Billion)
  40. France Cell-Based Products Regenerative Medicines Market, By Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample